Codexis (CDXS) Files $100M IPO
Codexis, Inc. (Nasdaq: CDXS) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $100 million. The company plans to list on the NASDAQ under the stock symbol "CDXS".
The offering is being made through Credit Suisse, Goldman Sachs, Piper Jaffray, RBC Capital Markets and Thomas Weisel Partners.
Codexis is a leading developer of proprietary biocatalysts that we believe have the potential to revolutionize chemistry-based manufacturing processes across a variety of industries. [BCS]
Stocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
